145 related articles for article (PubMed ID: 22518834)
1. MAPK signaling in the quadriceps of patients with chronic obstructive pulmonary disease.
Lemire BB; Debigaré R; Dubé A; Thériault ME; Côté CH; Maltais F
J Appl Physiol (1985); 2012 Jul; 113(1):159-66. PubMed ID: 22518834
[TBL] [Abstract][Full Text] [Related]
2. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease.
Doucet M; Russell AP; Léger B; Debigaré R; Joanisse DR; Caron MA; LeBlanc P; Maltais F
Am J Respir Crit Care Med; 2007 Aug; 176(3):261-9. PubMed ID: 17478621
[TBL] [Abstract][Full Text] [Related]
3. MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD.
Natanek SA; Riddoch-Contreras J; Marsh GS; Hopkinson NS; Moxham J; Man WD; Kemp PR; Polkey MI
COPD; 2013 Oct; 10(5):618-24. PubMed ID: 23844868
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the FoxO1/MuRF1/Atrogin-1 Signaling Pathway in the Oxidative Stress-Induced Atrophy of Cultured Chronic Obstructive Pulmonary Disease Myotubes.
Pomiès P; Blaquière M; Maury J; Mercier J; Gouzi F; Hayot M
PLoS One; 2016; 11(8):e0160092. PubMed ID: 27526027
[TBL] [Abstract][Full Text] [Related]
5. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
6. p38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary disease.
Riddoch-Contreras J; George T; Natanek SA; Marsh GS; Hopkinson NS; Tal-Singer R; Kemp P; Polkey MI
COPD; 2012 Apr; 9(2):142-50. PubMed ID: 22409248
[TBL] [Abstract][Full Text] [Related]
7. Peroxynitrite induces degradation of myosin heavy chain via p38 MAPK and muscle-specific E3 ubiquitin ligases in C2 skeletal myotubes.
Rom O; Kaisari S; Reznick AZ; Aizenbud D
Adv Exp Med Biol; 2015; 832():1-8. PubMed ID: 25315626
[TBL] [Abstract][Full Text] [Related]
8. Cigarette smoke and muscle catabolism in C2 myotubes.
Rom O; Kaisari S; Aizenbud D; Reznick AZ
Mech Ageing Dev; 2013; 134(1-2):24-34. PubMed ID: 23262287
[TBL] [Abstract][Full Text] [Related]
9. Activation of protein synthesis, regeneration, and MAPK signaling pathways following repeated bouts of eccentric cycling.
Valladares-Ide D; Peñailillo L; Collao N; Marambio H; Deldicque L; Zbinden-Foncea H
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1131-E1139. PubMed ID: 31593504
[TBL] [Abstract][Full Text] [Related]
10. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss.
Jin B; Li YP
J Cell Biochem; 2007 Mar; 100(4):960-9. PubMed ID: 17131360
[TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle dysfunction in idiopathic pulmonary arterial hypertension.
Batt J; Ahmed SS; Correa J; Bain A; Granton J
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):74-86. PubMed ID: 23972212
[TBL] [Abstract][Full Text] [Related]
12. High-power resistance exercise induces MAPK phosphorylation in weightlifting trained men.
Galpin AJ; Fry AC; Chiu LZ; Thomason DB; Schilling BK
Appl Physiol Nutr Metab; 2012 Feb; 37(1):80-7. PubMed ID: 22220922
[TBL] [Abstract][Full Text] [Related]
13. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease.
Plant PJ; Brooks D; Faughnan M; Bayley T; Bain J; Singer L; Correa J; Pearce D; Binnie M; Batt J
Am J Respir Cell Mol Biol; 2010 Apr; 42(4):461-71. PubMed ID: 19520920
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle hypertrophy and atrophy signaling pathways.
Glass DJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):1974-84. PubMed ID: 16087388
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoke-induced skeletal muscle atrophy is associated with up-regulation of USP-19 via p38 and ERK MAPKs.
Liu Q; Xu WG; Luo Y; Han FF; Yao XH; Yang TY; Zhang Y; Pi WF; Guo XJ
J Cell Biochem; 2011 Sep; 112(9):2307-16. PubMed ID: 21503966
[TBL] [Abstract][Full Text] [Related]
16. The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.
Foletta VC; White LJ; Larsen AE; Léger B; Russell AP
Pflugers Arch; 2011 Mar; 461(3):325-35. PubMed ID: 21221630
[TBL] [Abstract][Full Text] [Related]
17. [The proteasome inhibitor MG132 attenuates skeletal muscle atrophy in a rat model of chronic obstructive pulmonary disease].
Ma BM; Liu ZH; Liang ZK; Guan LJ; Wang XL
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):441-6. PubMed ID: 24103208
[TBL] [Abstract][Full Text] [Related]
18. Branched-chain amino acids reduce hindlimb suspension-induced muscle atrophy and protein levels of atrogin-1 and MuRF1 in rats.
Maki T; Yamamoto D; Nakanishi S; Iida K; Iguchi G; Takahashi Y; Kaji H; Chihara K; Okimura Y
Nutr Res; 2012 Sep; 32(9):676-83. PubMed ID: 23084640
[TBL] [Abstract][Full Text] [Related]
19. Atrogin-1, MuRF1, and FoXO, as well as phosphorylated GSK-3beta and 4E-BP1 are reduced in skeletal muscle of chronic spinal cord-injured patients.
Léger B; Senese R; Al-Khodairy AW; Dériaz O; Gobelet C; Giacobino JP; Russell AP
Muscle Nerve; 2009 Jul; 40(1):69-78. PubMed ID: 19533653
[TBL] [Abstract][Full Text] [Related]
20. MAFbx, MuRF1, and the stress-activated protein kinases are upregulated in muscle cells during total knee arthroplasty.
Bailey AN; Hocker AD; Vermillion BR; Smolkowski K; Shah SN; Jewett BA; Dreyer HC
Am J Physiol Regul Integr Comp Physiol; 2012 Aug; 303(4):R376-86. PubMed ID: 22761181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
